Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.
Market TrendsIndia's rodent-borne virus burden is vast, undertracked, and commercially underserved. The One Health gap pharma leaders must understand.
Market TrendsVyvgart's FDA approval story is one of the fastest in rare disease. Get the full timeline, indications, side effects, and dosing in one place.
Market TrendsIndia's top 11 generic pharma exporters powering affordable healthcare across 150+ countries worldwide.
ResearchExercise is a message your cells understand. Explore how movement reshapes metabolism, resilience, and healthy aging.
Market TrendsHantavirus cases linked to Indian travellers sparked concern. Learn how it spreads, what ICMR says, and who may be at risk.
Market TrendsHantavirus and the flu share early symptoms, but only one can turn deadly. Know the key differences and warning signs.
Market TrendsPCOS renamed PMOS May 2026 | The 14-year story, why old name harmed patients, metabolic implications and what changes for diagnosed women.
ResearchGene editing revolution | CRISPR/Cas9, base editing, prime editing, clinical applications & manufacturing challenges explained.
Market TrendsBreztri Aerosphere dosing for COPD and asthma — approved doses, special populations, clinical trial evidence and prescribing precautions explained.
Market TrendsYour 2026 pharma IT calendar | GPACTS, HIMSS26, INTERPHEX, CPHI and 7 more must-attend AI and tech conferences for pharma leaders worldwide.
Market TrendsAndes hantavirus vs COVID-19 compared transmission, fatality rates, therapeutics and pandemic preparedness strategy for pharma leaders.
Market TrendsHantavirus in India seroprevalence evidence, clinical cases, surveillance gaps and what pharma and public health leaders must know.